West M W, Biggs T A, Tavares E, Lankford M F, Myers R D
Department of Pharmacology and Center for Alcohol and Drug Abuse Studies, School of Medicine, East Carolina University, Greenville, NC 27858, USA.
Alcohol. 1998 Apr;15(3):239-47. doi: 10.1016/s0741-8329(97)00126-2.
A key question related to the role of acetaldehyde and aldehyde adducts in alcoholism concerns their relationship to the genetic mechanisms underlying drinking. Experimentally, the low-alcohol-drinking (LAD) rat represents a standard rodent model having a strong aversion to alcohol. In these experiments, preferences for water vs. alcohol, offered in concentrations from 3% to 30%, were determined over 10 days in adult LAD rats (N = 6 per group). Then a saline vehicle or either 10 or 20 mg/kg of the aldehyde dehydrogenase (AIDH) inhibitor, cyanamide, was injected s.c. twice daily for 3 days. Secondly, either 0.5 or 1.0 microg of tetrahydropapaveroline (THP) was infused i.c.v. twice daily for 3 days in LAD rats (N = 8) and, as a genetic control, THP also was infused identically in Sprague-Dawley (SD) rats (N = 8). The results showed that the lower and higher doses of cyanamide augmented alcohol intakes in 33% and 50% of the LAD rats, respectively, with the patterns of drinking resembling that of genetic high-alcohol-drinking HAD or P rats. Although i.c.v. infusions of THP had little effect on alcohol preference of LAD rats, alcohol drinking was enhanced significantly in the SD rats. In a supplementary study, 200 microg of 6-hydroxydopamine (6-OHDA) also was infused i.c.v. in LAD rats (N = 7) on two consecutive days; no change occurred in the characteristic aversion to alcohol. These findings suggest that in certain individuals, a perturbation in the synthesis of AIDH can modify the genetically based aversion to alcohol, thus precipitating the liability for alcoholism. In that neither THP nor 6-OHDA lesioning exerted any effect on the genetic nondrinking LAD animal suggests that an unknown endogenous factor in the brain must underlie the cyanamide-induced shift to alcohol preference. We conclude that the genetic elements that normally prevent the progression to addictive drinking in most individuals appear to be invariant and irreversible.
与乙醛和醛加合物在酒精中毒中的作用相关的一个关键问题涉及其与饮酒潜在遗传机制的关系。在实验中,低饮酒量(LAD)大鼠是一种对酒精有强烈厌恶感的标准啮齿动物模型。在这些实验中,测定了成年LAD大鼠(每组N = 6)在10天内对浓度为3%至30%的水与酒精的偏好。然后,每天皮下注射两次生理盐水或10或20毫克/千克的醛脱氢酶(AIDH)抑制剂氰胺,持续3天。其次,在LAD大鼠(N = 8)中,每天两次脑室内注射0.5或1.0微克的四氢罂粟碱(THP),持续3天,并且作为遗传对照,在Sprague-Dawley(SD)大鼠(N = 8)中也进行相同的THP注射。结果表明,较低剂量和较高剂量的氰胺分别使33%和50%的LAD大鼠酒精摄入量增加,其饮酒模式类似于遗传高饮酒量的HAD或P大鼠。虽然脑室内注射THP对LAD大鼠的酒精偏好影响不大,但SD大鼠的酒精饮用量显著增加。在一项补充研究中,连续两天对LAD大鼠(N = 7)脑室内注射200微克的6-羟基多巴胺(6-OHDA);对酒精的特征性厌恶没有改变。这些发现表明,在某些个体中,AIDH合成的扰动可以改变基于遗传的对酒精的厌恶,从而引发酒精中毒的倾向。由于THP和6-OHDA损伤对遗传上不饮酒的LAD动物均无任何影响,这表明大脑中一个未知的内源性因素必定是氰胺诱导的向酒精偏好转变的基础。我们得出结论,在大多数个体中通常阻止发展为成瘾性饮酒的遗传因素似乎是不变且不可逆的。